MetaCap

Who Owns ARS Pharmaceuticals Stock?

NASDAQ: SPRYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.96-0.40 (-11.90%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
85.56%
Institutional holders
262
  • Institutions 80.7%
  • Insiders 19.3%
  • Public and other 0.0%

Who owns ARS Pharmaceuticals stock?

Institutional investors own about 85.6% of ARS Pharmaceuticals's shares, spread across 262 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 19.25% of SPRY.

The largest institutional holders are RA Capital Management, L.P. (10.80%), Rubric Capital Management LP (8.50%) and Orbimed Advisors LLC. (8.24%). Together, the top 10 institutions control 57.5% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their SPRY positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of SPRY

ARS Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
RA Capital Management, L.P.10.86M10.80%0.0%
Rubric Capital Management LP8.54M8.50%+6.8%
Orbimed Advisors LLC.8.29M8.24%0.0%
Deerfield Management Company, L.P7.50M7.46%0.0%
Blackrock Inc.5.58M5.55%+5.1%
SR One Capital Management, LP4.01M3.99%0.0%
State Street Corporation3.69M3.67%-1.1%
UBS Group AG3.66M3.65%+89.0%
Tyro Capital Management LLC3.20M3.18%-28.2%
Vanguard Capital Management LLC2.50M2.49%-2.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of SPRY

ARS Pharmaceuticals top fund holders
FundShares% Held
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.18M2.16%
SmallCap World Fund Inc1.91M1.90%
abrdn Healthcare Opportunities Fund1.81M1.80%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.75M1.74%
iShares Trust-iShares Russell 2000 ETF1.62M1.61%
abrdn Healthcare Investors1.57M1.57%
General American Investors Company, Inc.908.43K0.90%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund746.06K0.74%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund708.69K0.70%
abrdn Life Sciences Investors651.54K0.65%

Frequently asked questions

Who is the largest shareholder of ARS Pharmaceuticals?

RA Capital Management, L.P. is the largest institutional shareholder of SPRY, owning 10.80% of shares outstanding (10.86M shares) as of its latest 13F filing.

What percentage of ARS Pharmaceuticals is owned by institutions?

Institutions own about 85.6% of SPRY shares and 106.0% of the public float.

How much of ARS Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 19.25% of SPRY shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related